CBP Issues Guidance on Tariff Changes for Infant Formula Base Powder Imports
CBP provided some guidance for how importers of infant formula base powder can make use of the temporary suspension of tariffs on baby formula (see 2210110041). CBP "will provide duty-free treatment of the eligible infant formula base powder entered or…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
withdrawn from warehouse for consumption on or after 12:01 AM Eastern daylight time on October 13, 2022, through 11:59 PM Eastern Standard time on December 31, 2022," it said. "Duty-free treatment will only be provided to importers of base powder to be manufactured into infant formula authorized to be marketed in the United States or subject to an enforcement discretion letter from the Food and Drug Administration (FDA)." The duty-free treatment is "limited to certain infant formula base powder classifiable under HTS subheading 1901.90.62 and must be exported to the United States on or before November 14, 2022," CBP said. "Authorized importers seeking duty-free treatment for qualifying shipments will make a quota type entry utilizing subheading 9903.19.23. Any shipment qualifying for duty-free treatment under subheading 9903.19.23 will not be subject to any additional safeguard duties that may be imposed under subchapter IV of Chapter 99 of the HTS. If the import quota threshold is met before December 31, 2022, duty-free treatment will no longer be granted."